Literature DB >> 12849290

Potential of statins for the treatment of multiple sclerosis.

David Baker1, Peter Adamson, John Greenwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12849290     DOI： 10.1016/s1474-4422(03)00256-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

Review 1.  Statins for multiple sclerosis.

Authors:  Jin Wang; Yousheng Xiao; Man Luo; Hongye Luo
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles.

Authors:  Oliver Neuhaus; Olaf Stüve; Scott S Zamvil; Hans-Peter Hartung
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  [Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators].

Authors:  O Neuhaus; H Wiendl; B C Kieseier; J J Archelos; H-P Hartung
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

Review 4.  The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.

Authors:  Nusrat Shafiq; Samir Malhotra; Promila Pandhi; Anil Grover
Journal:  J Negat Results Biomed       Date:  2005-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.